HIV/AIDS Co-Infection

Global Health Institute joins with India to control deadly HIV/TB co-infection

Published in AIDS Weekly, March 19th, 2007

Researchers at Emory University's Global Health Institute and the Emory Vaccine Center are collaborating with one of India's premier research centers in a push to enhance the immune systems of people infected with both HIV and tuberculosis.

Located in New Delhi, the institute, known as the International Center for Genetic Engineering and Biotechnology (ICGEB), will provide state-of-the-art lab space for newly recruited Emory scientists and their ICGEB collaborators to form the Center for Global Vaccines.

"Our initial studies will focus on the basic aspects of the HIV/TB co-infection. There is an interesting interplay between HIV and TB," says Rafi...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2007-03-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry